Skip to main content
IRMD
NASDAQ Industrial Applications And Services

iRadimed 10-Q Details Record Q3: $24.2M Revenue, $0.51 EPS, $0.20 Dividend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$76.4
Mkt Cap
$980.506M
52W Low
$75.75
52W High
$107.9
52W Position info
0.9% above low
Off High info
29% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

IRMD is trading near its 52-week low of $75.75 (0.9% above the low) on elevated volume (1.8× avg).

Summary

iRadimed's Q3 10-Q backs up the morning's record $24.2 million revenue and $0.51 EPS, showing gross margin down to 76% and cash up to $63.3 million, plus a $0.20 quarterly dividend and a CEO 10b5-1 plan for up to 50,000 shares.


Key Events · Earnings and Guidance · IRMD

  • Record Q3 Revenue of $24.2M

    Revenue rose 14% to $24.2 million from $21.2 million a year earlier, with international sales up 45% to $4.5 million and U.S. sales up 9% to $19.7 million.

  • Gross Margin Slips to 76%

    Gross profit of $18.5 million came at a 76% margin versus 78% a year ago, which management attributes to initial production inefficiencies on new product manufacturing.

  • Cash Builds to $63.3M

    Cash and equivalents reached $63.3 million at September 30 from $51.2 million at December 31, 2025, after $21.2 million of nine-month operating cash flow and $7.7 million of dividends paid.

  • $0.20 Quarterly Dividend Declared

    The board declared a regular quarterly cash dividend of $0.20 per share, payable November 27, 2026 to stockholders of record on November 13, 2026.


Analysis · IRMD · Industrial Applications And Services

With the headline numbers already out this morning via 8-K and newswires, the 10-Q's real value lies in the underlying quality of the quarter and the balance sheet. Revenue of $24.2 million rose 14%, but gross margin slipped to 76% from 78% on initial production inefficiencies for new products — growth is coming partly at the cost of margin. Cash built to $63.3 million from $51.2 million at year-end on $21.2 million of nine-month operating cash flow, and the board declared the regular $0.20 quarterly dividend payable November 27. Separately, CEO Roger Susi put a 10b5-1 plan in place on August 7 covering up to 50,000 shares through February 10, 2027 — a pre-scheduled selling window, not a discretionary sale.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IRMD was trading at $76.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $980.5M. The 52-week trading range was $75.75 to $107.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IRMD - Latest Insights

IRMD
Oct 30, 2026, 8:37 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $83.50
Real-time Price: $84.52 info
Change: +$1.02 (+1%) info
Market Cap: $1.081B info
IRMD
Oct 30, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $83.50
Real-time Price: $84.52 info
Change: +$1.02 (+1%) info
Market Cap: $1.081B info
IRMD
Aug 21, 2026, 5:48 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $87.85
Real-time Price: $84.52 info
Change: -$3.33 (-4%) info
Market Cap: $1.081B info
IRMD
Jul 31, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $95.21
Real-time Price: $84.52 info
Change: -$10.69 (-11%) info
Market Cap: $1.081B info
IRMD
Jul 31, 2026, 8:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $95.21
Real-time Price: $84.52 info
Change: -$10.69 (-11%) info
Market Cap: $1.081B info